NCT07065994

Brief Summary

This study aims to determine the effect of virtual reality glasses on pain and anxiety levels in colorectal surgery patients. This study is a single-center, parallel-group, open-label, randomized controlled clinical trial. This study will be conducted with 60 patients who underwent colorectal surgery between August 2025 and December 2025. Participants will be randomized into two groups as the intervention group (n=30) and the control group (n=30). All patients in the experimental and control groups will be asked to fill out the "Informed Consent Form" the day before the surgery, and the patients who agree to participate in the study will be asked to fill out the "Patient Introduction Form" and the "State Anxiety Scale" by the researchers. The "Simulator Illness Questionnaire" used in the Virtual Reality disease field will be applied to the experimental group to determine their physiological conditions before the application. Then, a relaxing music-backgrounded video containing images of nature will be watched with virtual reality glasses for 10-15 minutes the day before the surgery. Then, the "Simulator Illness Questionnaire" and the "State Anxiety Scale" will be filled out again. The "Simulator Illness Questionnaire" will be applied to the patients 2 hours after their transfer from the postoperative care unit to the clinic, which is the most appropriate time after the surgery, when their vital signs have stabilized and clinical compliance has been achieved, and their physiological conditions before the application will be determined. Then, the patients in the experimental group will be asked to watch a relaxing music-backgrounded video containing images of nature for 10-15 minutes with virtual reality glasses. The researcher will perform the video with virtual reality glasses in the patient rooms and beds. Afterwards, the "Simulator Disease Survey" will be repeated. There will be no compelling effect that will negatively affect the health of the patients during the application, and the application will be terminated when the patients feel uncomfortable. A safe environment will be created so that there are no objects around the patients that they can bump into or trip over. A 5-10 minute trial period will be performed at the beginning with the observer and the virtual reality glasses will be applied. The patient will be able to end the study at any time. If the patients use glasses/lenses, compliance will be checked. No intervention will be applied to the control group patients and the routine practices of the clinic will continue. All patients in the experimental and control groups will be assessed for pain with the Visual Analog Scale (VAS) at the 2nd and 4th hours and the "State Anxiety Scale" will be applied.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 26, 2025

Completed
19 days until next milestone

First Posted

Study publicly available on registry

July 15, 2025

Completed
17 days until next milestone

Study Start

First participant enrolled

August 1, 2025

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

December 19, 2025

Status Verified

December 1, 2025

Enrollment Period

5 months

First QC Date

June 26, 2025

Last Update Submit

December 12, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • Visual Analog Scale (VAS)

    VAS is a scale consisting of 10 cm lines (0-10 cm) used to assess pain. 0 means "no pain" and 10 means "unbearable pain". In this method, the patient is asked to mark the number between these two extreme points and the degree of pain (F. E. Aslan, 2002).

    preoperative, postoperative 2 hours, postoperative 4 hours

  • Spielberger State and Trait Anxiety Inventory (STAI)

    STAI, which is widely used and still valid, was developed by Spielberger, Gorsuch and Lushene in 1970, and its Turkish language and content validity was made by Öner and Le Compte in 1983. It consists of 2 subscales covering 20 statements measuring state and trait anxiety. The State Anxiety Subscale (STAI-S) expresses how an individual feels at a certain moment and under certain conditions; and the Trait Anxiety Subscale (STAI-T) expresses how they generally feel. The inventory is answered through 4-dimensional definitions. The feelings and behaviors expressed in the State Anxiety Subscale items are specified by selecting one of the options "(1) None, (2) Some, (3) A lot and (4) Completely" according to the severity of such experiences. The feelings and behaviors expressed in the Trait Anxiety Subscale items are specified according to their frequency levels; It is expressed as "(1) Almost Never, (2) Sometimes, (3) A Lot of the Time, and (4) Almost Always". High scores from each subsca

    preoperative, postoperative 2 hours, postoperative 4 hours

  • Simulator Sickness Questionnaire (SSQ)

    Simulation Sickness Questionnaire (SSQ) is widely used to measure Virtual Reality sickness (Sevinc and Berkman, 2020, Igoshina et al. 2022). Simulator sickness questionnaire consists of 16 questions. These questions are located under 4 components: nausea (N), oculomotor (O), disorientation (D) and weighted total (T). The majority of studies conducted using SSQ reported only the Total Score score (Sevinc, and Berkman, 2020).

    preoperative, postoperative 2 hours

Study Arms (2)

Experimental

EXPERIMENTAL

All patients in the experimental group will be asked to fill out the "Informed Consent Form" the day before the surgery, and the patients who agree to participate in the study will be asked to fill out the "Patient Introduction Form" and the "State Anxiety Scale" by the researchers. The "Simulator Illness Questionnaire" used in the Virtual Reality disease field will be applied to the experimental group to determine their physiological status before the application. Then, a relaxing music-backgrounded video containing nature images will be watched with virtual reality glasses for 10-15 minutes the day before the surgery. Then, the "Simulator Illness Questionnaire" and the "State Anxiety Scale" will be filled out again. The "Simulator Illness Questionnaire" will be applied to the patients at the most appropriate time after the surgery, when their vital signs have stabilized and clinical compliance has been achieved, and 2 hours after their transfer from the postoperative care unit to th

Device: Virtual Reality Glasses Application

Control

NO INTERVENTION

All patients in the control group will be given permission with the "Informed Consent Form" the day before the surgery, and the patients who agree to participate in the study will be asked to fill out the "Patient Introduction Form" and the "State Anxiety Scale" by the researchers. No intervention will be applied to the control group patients, and the routine practices of the clinic will continue. All patients in the experimental and control groups will be assessed for pain with the Visual Analog Scale (VAS) at the 2nd and 4th hours, and the "State Anxiety Scale" will be applied.

Interventions

The day before the surgery, you will be shown a video of nature images with relaxing music for 10-15 minutes using virtual reality glasses.

Experimental

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients who are 18 years of age or older, 65 years of age or younger,
  • Who will undergo laparoscopic colorectal surgery,
  • Who do not develop any complications during or after the surgical procedure,
  • Who volunteer to participate in the study will be included in the study.

You may not qualify if:

  • Patients who have not undergone laparoscopic surgery,
  • Those who are hemodynamically unstable,
  • Those with neurological or psychological problems,
  • Those who are transferred to the intensive care unit after surgery,
  • Emergency and unplanned cases,
  • Those with visual, auditory or systemic disorders,
  • Those who have balance problems,
  • Those diagnosed with hypertension or hypotension,
  • Patients diagnosed with anxiety disorder or epilepsy will be excluded from the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ankara Yıldırım Beyazıt University

Ankara, Turkey (Türkiye)

Location

MeSH Terms

Conditions

PainAnxiety Disorders

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

June 26, 2025

First Posted

July 15, 2025

Study Start

August 1, 2025

Primary Completion

December 31, 2025

Study Completion

December 31, 2025

Last Updated

December 19, 2025

Record last verified: 2025-12

Locations